Zinc in PDB 5sf9: Crystal Structure of Human Phosphodiesterase 10 in Complex with 2- Methyl-3-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinoxaline
Enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2- Methyl-3-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinoxaline
All present enzymatic activity of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2- Methyl-3-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinoxaline:
3.1.4.17;
Protein crystallography data
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2- Methyl-3-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinoxaline, PDB code: 5sf9
was solved by
C.Joseph,
K.Groebke-Zbinden,
J.Benz,
D.Schlatter,
M.G.Rudolph,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
43.78 /
2.37
|
Space group
|
H 3
|
Cell size a, b, c (Å), α, β, γ (°)
|
135.64,
135.64,
235.889,
90,
90,
120
|
R / Rfree (%)
|
17.5 /
22.9
|
Other elements in 5sf9:
The structure of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2- Methyl-3-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinoxaline also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 2- Methyl-3-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinoxaline
(pdb code 5sf9). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 4 binding sites of Zinc where determined in the
Crystal Structure of Human Phosphodiesterase 10 in Complex with 2- Methyl-3-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinoxaline, PDB code: 5sf9:
Jump to Zinc binding site number:
1;
2;
3;
4;
Zinc binding site 1 out
of 4 in 5sf9
Go back to
Zinc Binding Sites List in 5sf9
Zinc binding site 1 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 2- Methyl-3-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinoxaline
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2- Methyl-3-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinoxaline within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn801
b:47.5
occ:1.00
|
O
|
A:HOH929
|
2.1
|
41.4
|
1.0
|
NE2
|
A:HIS529
|
2.1
|
44.4
|
1.0
|
OD2
|
A:ASP564
|
2.1
|
49.5
|
1.0
|
NE2
|
A:HIS563
|
2.1
|
36.8
|
1.0
|
OD1
|
A:ASP674
|
2.2
|
47.6
|
1.0
|
O
|
A:HOH935
|
2.3
|
47.0
|
1.0
|
CG
|
A:ASP674
|
3.0
|
44.1
|
1.0
|
CE1
|
A:HIS529
|
3.1
|
42.4
|
1.0
|
CD2
|
A:HIS563
|
3.1
|
38.6
|
1.0
|
CD2
|
A:HIS529
|
3.1
|
45.0
|
1.0
|
CG
|
A:ASP564
|
3.1
|
44.8
|
1.0
|
OD2
|
A:ASP674
|
3.1
|
45.3
|
1.0
|
CE1
|
A:HIS563
|
3.2
|
40.0
|
1.0
|
OD1
|
A:ASP564
|
3.6
|
41.1
|
1.0
|
MG
|
A:MG802
|
3.9
|
44.0
|
1.0
|
CD2
|
A:HIS525
|
4.1
|
45.4
|
1.0
|
ND1
|
A:HIS529
|
4.2
|
43.6
|
1.0
|
O
|
A:HOH946
|
4.2
|
41.8
|
1.0
|
CG
|
A:HIS563
|
4.2
|
38.2
|
1.0
|
CG
|
A:HIS529
|
4.2
|
40.7
|
1.0
|
ND1
|
A:HIS563
|
4.2
|
38.6
|
1.0
|
CB
|
A:ASP564
|
4.4
|
43.8
|
1.0
|
CB
|
A:ASP674
|
4.4
|
44.1
|
1.0
|
NE2
|
A:HIS525
|
4.4
|
46.7
|
1.0
|
O
|
A:HOH910
|
4.5
|
37.2
|
1.0
|
CG2
|
A:VAL533
|
4.8
|
35.5
|
1.0
|
CA
|
A:ASP674
|
4.9
|
42.9
|
1.0
|
O
|
A:ASP674
|
5.0
|
43.4
|
1.0
|
|
Zinc binding site 2 out
of 4 in 5sf9
Go back to
Zinc Binding Sites List in 5sf9
Zinc binding site 2 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 2- Methyl-3-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinoxaline
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2- Methyl-3-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinoxaline within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn801
b:44.5
occ:1.00
|
OD1
|
B:ASP674
|
2.0
|
40.9
|
1.0
|
OD2
|
B:ASP564
|
2.0
|
41.5
|
1.0
|
O
|
B:HOH913
|
2.1
|
32.6
|
1.0
|
NE2
|
B:HIS563
|
2.2
|
36.9
|
1.0
|
NE2
|
B:HIS529
|
2.2
|
35.0
|
1.0
|
O
|
B:HOH944
|
2.3
|
46.9
|
1.0
|
CG
|
B:ASP674
|
2.9
|
39.0
|
1.0
|
CD2
|
B:HIS563
|
3.1
|
40.7
|
1.0
|
CG
|
B:ASP564
|
3.1
|
42.8
|
1.0
|
CD2
|
B:HIS529
|
3.2
|
37.0
|
1.0
|
OD2
|
B:ASP674
|
3.2
|
41.4
|
1.0
|
CE1
|
B:HIS529
|
3.2
|
36.2
|
1.0
|
CE1
|
B:HIS563
|
3.2
|
38.7
|
1.0
|
OD1
|
B:ASP564
|
3.6
|
43.9
|
1.0
|
MG
|
B:MG802
|
3.8
|
38.5
|
1.0
|
O
|
B:HOH943
|
3.9
|
29.9
|
1.0
|
CD2
|
B:HIS525
|
4.2
|
48.1
|
1.0
|
CG
|
B:HIS563
|
4.3
|
36.4
|
1.0
|
ND1
|
B:HIS563
|
4.3
|
38.0
|
1.0
|
CB
|
B:ASP564
|
4.3
|
41.2
|
1.0
|
ND1
|
B:HIS529
|
4.3
|
39.4
|
1.0
|
CG
|
B:HIS529
|
4.3
|
36.2
|
1.0
|
CB
|
B:ASP674
|
4.3
|
40.0
|
1.0
|
NE2
|
B:HIS525
|
4.6
|
47.1
|
1.0
|
O
|
B:HOH919
|
4.8
|
40.6
|
1.0
|
CA
|
B:ASP674
|
4.8
|
35.9
|
1.0
|
CG2
|
B:VAL533
|
4.8
|
36.4
|
1.0
|
O
|
B:ASP674
|
4.9
|
42.3
|
1.0
|
|
Zinc binding site 3 out
of 4 in 5sf9
Go back to
Zinc Binding Sites List in 5sf9
Zinc binding site 3 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 2- Methyl-3-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinoxaline
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2- Methyl-3-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinoxaline within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Zn801
b:43.6
occ:1.00
|
NE2
|
C:HIS529
|
2.1
|
36.4
|
1.0
|
OD2
|
C:ASP564
|
2.1
|
42.8
|
1.0
|
OD1
|
C:ASP674
|
2.1
|
50.5
|
1.0
|
O
|
C:HOH926
|
2.2
|
33.4
|
1.0
|
NE2
|
C:HIS563
|
2.2
|
36.8
|
1.0
|
O
|
C:HOH933
|
2.3
|
44.0
|
1.0
|
CG
|
C:ASP674
|
3.0
|
41.5
|
1.0
|
CD2
|
C:HIS563
|
3.0
|
36.4
|
1.0
|
CD2
|
C:HIS529
|
3.0
|
37.8
|
1.0
|
OD2
|
C:ASP674
|
3.1
|
41.8
|
1.0
|
CE1
|
C:HIS529
|
3.2
|
39.6
|
1.0
|
CG
|
C:ASP564
|
3.2
|
39.3
|
1.0
|
CE1
|
C:HIS563
|
3.3
|
36.1
|
1.0
|
OD1
|
C:ASP564
|
3.7
|
40.3
|
1.0
|
MG
|
C:MG802
|
3.8
|
39.1
|
1.0
|
CD2
|
C:HIS525
|
4.1
|
41.1
|
1.0
|
O
|
C:HOH955
|
4.2
|
60.6
|
1.0
|
O
|
C:HOH954
|
4.2
|
34.2
|
1.0
|
CG
|
C:HIS529
|
4.2
|
35.2
|
1.0
|
CG
|
C:HIS563
|
4.2
|
33.6
|
1.0
|
ND1
|
C:HIS529
|
4.3
|
40.6
|
1.0
|
ND1
|
C:HIS563
|
4.3
|
35.1
|
1.0
|
CB
|
C:ASP564
|
4.3
|
37.9
|
1.0
|
CB
|
C:ASP674
|
4.4
|
43.5
|
1.0
|
O
|
C:HOH912
|
4.5
|
42.4
|
1.0
|
NE2
|
C:HIS525
|
4.5
|
51.9
|
1.0
|
CA
|
C:ASP674
|
4.8
|
44.7
|
1.0
|
CG2
|
C:VAL533
|
4.9
|
43.8
|
1.0
|
O
|
C:ASP674
|
5.0
|
48.6
|
1.0
|
|
Zinc binding site 4 out
of 4 in 5sf9
Go back to
Zinc Binding Sites List in 5sf9
Zinc binding site 4 out
of 4 in the Crystal Structure of Human Phosphodiesterase 10 in Complex with 2- Methyl-3-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinoxaline
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Crystal Structure of Human Phosphodiesterase 10 in Complex with 2- Methyl-3-[(1-Methyl-4-Phenylimidazol-2-Yl)Methoxy]Quinoxaline within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Zn801
b:60.5
occ:1.00
|
OD2
|
D:ASP564
|
2.0
|
61.3
|
1.0
|
NE2
|
D:HIS529
|
2.1
|
51.4
|
1.0
|
NE2
|
D:HIS563
|
2.1
|
54.4
|
1.0
|
O
|
D:HOH905
|
2.2
|
42.9
|
1.0
|
OD1
|
D:ASP674
|
2.2
|
60.9
|
1.0
|
O
|
D:HOH910
|
2.4
|
53.6
|
1.0
|
CD2
|
D:HIS529
|
3.0
|
59.9
|
1.0
|
CD2
|
D:HIS563
|
3.0
|
59.0
|
1.0
|
CG
|
D:ASP564
|
3.2
|
55.3
|
1.0
|
CE1
|
D:HIS529
|
3.2
|
54.6
|
1.0
|
CE1
|
D:HIS563
|
3.2
|
54.9
|
1.0
|
CG
|
D:ASP674
|
3.3
|
61.3
|
1.0
|
OD2
|
D:ASP674
|
3.7
|
68.7
|
1.0
|
OD1
|
D:ASP564
|
3.8
|
54.4
|
1.0
|
O
|
D:HOH909
|
3.8
|
53.4
|
1.0
|
MG
|
D:MG802
|
4.0
|
57.1
|
1.0
|
CD2
|
D:HIS525
|
4.2
|
67.0
|
1.0
|
CG
|
D:HIS563
|
4.2
|
61.8
|
1.0
|
CG
|
D:HIS529
|
4.2
|
54.0
|
1.0
|
CB
|
D:ASP564
|
4.2
|
56.7
|
1.0
|
ND1
|
D:HIS529
|
4.2
|
53.9
|
1.0
|
ND1
|
D:HIS563
|
4.2
|
60.0
|
1.0
|
CB
|
D:ASP674
|
4.6
|
66.4
|
1.0
|
NE2
|
D:HIS525
|
4.6
|
68.9
|
1.0
|
O
|
D:ASP674
|
4.7
|
64.8
|
1.0
|
CG2
|
D:VAL533
|
4.7
|
63.7
|
1.0
|
CA
|
D:ASP674
|
4.9
|
62.4
|
1.0
|
|
Reference:
A.Tosstorff,
M.G.Rudolph,
J.C.Cole,
M.Reutlinger,
C.Kramer,
H.Schaffhauser,
A.Nilly,
A.Flohr,
B.Kuhn.
A High Quality, Industrial Data Set For Binding Affinity Prediction: Performance Comparison in Different Early Drug Discovery Scenarios. J.Comput.Aided Mol.Des. V. 36 753 2022.
ISSN: ESSN 1573-4951
PubMed: 36153472
DOI: 10.1007/S10822-022-00478-X
Page generated: Mon Oct 28 04:54:19 2024
|